Advanced Search

 

Study ID Status Title Patient Level Data
114269 Completed Partially-blind Immunogenicity and Safety Study of GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults. Study Listed on ClinicalStudyDataRequest.com
114270 Completed Immunogenicity and safety study of GSK Biologicals’ influenza vaccine Arepanrix™ (GSK2340274A) in adults 65 years of age or older Study Listed on ClinicalStudyDataRequest.com
114292 Completed A phase III study for evaluation of immunogenicity and reactogenicity of Fluarix™/Influsplit SSW® 2010/2011 in people aged 18 years or above Study Listed on ClinicalStudyDataRequest.com
114294 Terminated Observer-blind Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Adjuvanted Quadrivalent Influenza Candidate Vaccines (GSK2584786A) in Children Aged 6 to 35 Months Study Listed on ClinicalStudyDataRequest.com
114296 Completed A Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects with Moderate to Severe Plaque-Type Psoriasis Study Listed on ClinicalStudyDataRequest.com
114306 Completed Immunogenicity and safety of a booster dose of GlaxoSmithKline Biologicals’ IPV (PoliorixTM) in healthy Chinese toddlers Study Listed on ClinicalStudyDataRequest.com
114312 Completed A randomized, double-blind, placebo-controlled, parallel group study to compare GW766944 (an oral CCR3 receptor antagonist) versus placebo in patients with asthma and sputum eosinophilia. Study Listed on ClinicalStudyDataRequest.com
114347 Completed A single-blind, placebo-controlled study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of repeat ascending doses of GSK2018682 (S1P1 agonist) in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
114351 Completed Immunogenicity, reactogenicity and safety study of GlaxoSmithKline (GSK) Biologicals’ oral live attenuated human rotavirus (HRV) vaccine in healthy Taiwanese infants who received hepatitis B immunoglobulin after birth. Study Listed on ClinicalStudyDataRequest.com
114371 Completed Immunogenicity and safety study of GSK Biologicals’ cell culture derived pandemic influenza vaccines GSK2590066A and GSK2592984A administered to healthy adults 18 - 49 years old Study Listed on ClinicalStudyDataRequest.com
114379 Completed Safety study of GSK Biologicals’ human papillomavirus vaccine (GSK-580299) in healthy female control subjects from the GSK HPV-023 study
114387 Completed A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Three-Treatment, Three 6-Week Period Cross-Over, Multi-Center Study to Evaluate the Effect of Adding GSK2190915 300mg as Compared to Adding Montelukast 10mg or Placebo Tablets QD to Fluticasone Propionate/Salmeterol 250/50mcg Diskus BID Study Listed on ClinicalStudyDataRequest.com
114398 Completed Paroxetine Pharmacokinetics Gender Differences
114403 Completed A single-blinded, randomized, placebo-controlled, staggered-parallel, escalating dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2374697 in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
114417 Completed An exercise endurance study to evaluate the effects of treatment of Chronic Obstructive Pulmonary Disease (COPD) patients with a dual bronchodilator: GSK573719/GW642444. Study A Study Listed on ClinicalStudyDataRequest.com
114418 Completed An exercise endurance study to evaluate the effects of treatment of Chronic Obstructive Pulmonary Disease (COPD) patients with a dual bronchodilator: GSK573719/GW642444. Study B Study Listed on ClinicalStudyDataRequest.com
114422 Completed A Randomized, Placebo Controlled Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of GSK1322888 in Healthy Caucasian and Japanese Asian Adult Subjects Study Listed on ClinicalStudyDataRequest.com
114444 Completed Study to assess the replication of Porcine circovirus type 1 (PCV-1) GSK Biologicals’ oral live attenuated human rotavirus vaccine (444563) recipients aged 6 to 12 weeks who participated in 444563/022 (Rota-022), 444563/033 (Rota-033), 103477 (Rota-039) and 104480 (Rota-048)
114451 Completed Immunogenicity and Safety Study of GSK Biologicals' Seasonal (2010-2011) Influenza Vaccine Fluarix™ in Children Previously Vaccinated With GSK Biologicals' H1N1 Vaccine Pandemrix™ Study Listed on ClinicalStudyDataRequest.com
114452 Completed Immunogenicity and Safety Study of GSK Biologicals' Seasonal (2010-2011) Influenza Vaccine FluarixTM in Adolescents Previously Vaccinated With GSK Biologicals' H1N1 Vaccine PandemrixTM Study Listed on ClinicalStudyDataRequest.com
114454 Terminated Immunogenicity and safety of Fluarix™/ Influsplit SSW® 2010/2011 or Pandemrix™ Study Listed on ClinicalStudyDataRequest.com
114458 Completed A phase 2a study to evaluate the effect of rilapladib (SB-659032) on biomarkers related to the pathogenesis and progression of Alzheimer’s disease Study Listed on ClinicalStudyDataRequest.com
114460 Completed Safety, immunogenicity and efficacy against malaria in the sporozoite challenge model of one dose of Ad35.CS.01 malaria vaccine followed by two doses of malaria 257049 vaccine in healthy malaria-naïve adults Study Listed on ClinicalStudyDataRequest.com
114461 Completed Evaluating the impact of early versus delayed 5 alpha reductase inhibitor treatment on the risk of emergent surgery in men with benign prostatic hyperplasia
114462 Completed Evaluating the treatment patterns in men with benign prostatic hypertrophy (Marketscan database study)

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.